-
1 Comment
Hamilton Thorne Ltd is currently in a long term uptrend where the price is trading 25.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.0.
Hamilton Thorne Ltd's total revenue rose by 10.4% to $10M since the same quarter in the previous year.
Its net income has increased by 40.6% to $459K since the same quarter in the previous year.
Finally, its free cash flow grew by 493.7% to $2M since the same quarter in the previous year.
Based on the above factors, Hamilton Thorne Ltd gets an overall score of 5/5.
ISIN | CA4078911001 |
---|---|
Sector | Healthcare |
Industry | Medical Devices |
Exchange | V |
CurrencyCode | CAD |
Market Cap | 213M |
---|---|
PE Ratio | 48.33 |
Target Price | 2.37 |
Dividend Yield | 0.0% |
Beta | 0.54 |
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services. In addition, it manufactures and distributes products for reproductive medicine, including clinical and laboratory equipment and disposables, as well as complete installations of ART clinics; and bench top incubators, programmable freezers, loggers, alarms, cryo storage, and software systems and sensors for the safe preservation of medical and biological specimens used in ART and cell biology applications. Further, the company offers Cell-Tek Microscope Chamber, a product for controlling temperature, air flow, humidification, and air quality; laminar flow workstations, incubators, and related products; and artificial intelligence enabled CASA software, consumables, and image analysis systems for the ART and laboratory markets, as well as acts as a value-added reseller of a range of capital equipment and consumables. It sells its products and services through a direct sales force in the United States, Germany, France, Australia, Denmark, Spain, and the United Kingdom, as well as through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 75 countries. The company is headquartered in Beverly, Massachusetts.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for HTL.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025